OLMA insider buying and SEC filings, explained
Olema Pharmaceuticals, Inc. · CIK 1750284
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$13.1M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 23–24, 2026 | Sale | Cyrus Harmon (Director) sold 25,000 shares between Jul 23 and Jul 24 at about $11.65 ($291K). Holdings down 3% to 702,770 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 27, 2026 |
| Jan 20, 2026 | Sale | Cyrus Harmon (Director) sold 10,000 shares at about $26.88 ($269K). Holdings down 1% to 727,770 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Jan 14, 2026 | Sale | Cyrus Harmon (Director) sold 3,489 shares at about $29.12 ($102K). Holdings down <1% to 737,770 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 16, 2026 |
| Jan 13–15, 2026 | Sale | Shane William Charles Kovacs (Ch. Operating & Financial Off.) sold 103,822 shares between Jan 13 and Jan 15 at about $28.70 ($3.0M). Holdings down 43% to 139,727 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 15, 2026 |
| Jan 12, 2026 | Sale | David C. Myles (Ch. Discov. & Non-Clin Dev Off) sold 10,000 shares indirectly at about $28.34 ($283K). Indirect holdings down 6% to 144,846 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 14, 2026 |
| Dec 22, 2025 | Sale | Cyrus Harmon (Director) sold 2,881 shares at about $28.53 ($82K). Holdings down <1% to 741,259 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 29, 2025 |
| Dec 19–23, 2025 | Sale | Naseem Zojwalla (Chief Medical Officer) sold 269,509 shares between Dec 19, 2025 and Dec 23, 2025 at about $27.94 ($7.5M). Holdings down 98% to 4,488 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
| Dec 19, 2025 | Sale | David C. Myles (Ch. Discov. & Non-Clin Dev Off) sold 51,000 shares at about $30.46 ($1.6M). Holdings down 8% to 551,881 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 23, 2025 |
30 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow OLMA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.